Document is current

Article History

Accepted: 28 January 2022

First Online: 17 March 2022

Competing interests

: C.M.B. received a grant from Shire, was a member of the Shire Scientific Advisory Board, acted as a consultant for Idorsia, received a grant from Lundbeckfonden, acted as an author for and received a grant from Pearson, and was a member of the Equip Health Inc. Clinical Advisory Board. F.F.-A. received consultancy honorarium from Novo Nordisk and an editorial honorarium as editor-in-chief from Wiley. P.H. is a consultant to Takeda Pharmaceuticals, receives or has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry, and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, Blackwell Scientific Publications, BioMed Central and PLOS Medicine, and has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia and was a member of the ICD-11 Working Group for Eating Disorders and was Chair of the Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP. All views expressed in this paper are her own. All other authors declare no competing interests.